logo
Impact Radar
  • Overview
  • Impact Performance
  • Compare this company
  • All sources
    • Sign UpLog In
    logo

    Regeneron Pharmaceuticals | Sustainability & Chart

    US75886F1075

    Basic information on Regeneron Pharmaceuticals

    Location: United States

    Industry: Health Services

    Website

    knob-globe
    63%

    Impact Score

    Description Regeneron Pharmaceuticals

    Regeneron Pharmaceuticals is a biotechnology company inventing medicines for serious medical conditions, focusing on the discovery, development, and commercialization of pharmaceutical products.

    Regeneron Pharmaceuticals Sustainability Performance

    Renewable Energy
    Greenhouse Gas Emissions
    Supply Chain
    Waste Recycling
    Sustainable [100]
    Almost sustainable [67-99]
    Moderate [34-66]
    Not sustainable [0-33]
    No data
    We measure the sustainability of companies based on 12 criteria.Indicators range from 0 to 100: values from 0 to 33 are shown in red (“not sustainable”), values from 34 to 66 in yellow (“moderate”), values from 67 to 99 in light green (“almost sustainable”), and a value of 100 in green (“sustainable”). Learn more about our method.

    Compare Regeneron Pharmaceuticals with ...

    Regeneron Pharmaceuticals

    ?

    Impact Score

    knob-globe
    63%
    knob-globe
    0%
    Climate
    Society
    Gender

    Sources of sustainability performance

    MetricValueUnitYearPDF NamePDF Page
    CEO Pay Ratio
    CEO nameLeonard S. Schleifer2025Regeneron 2025 Annual Report.pdf100
    CEO-to-median-salary-ratio42Ratio2025Regeneron 2026 Proxy Statement.pdf102
    Employee Turnover Rate
    Employee turnover7,4%20252025RR.pdf68
    Gender Pay Gap
    Unadjusted gender pay gap99,5%20242024RR.pdf40
    Glass Ceiling
    Women in workforce50%20252025RR.pdf68
    Women in management36%20252025RR.pdf68
    Greenhouse Gas Emissions
    Number of employees15 410people2025Regeneron 2025 Annual Report.pdf38
    Combined scope 1 & 2 emissions150 100Metric Tons CO2e20252025RR.pdf69
    Harassment and Discrimination at the Workplace
    Incident notification mechanismYes2025code_of_business_conduct_and_ethics.pdf10
    Confidentiality mechanismsYes2025code_of_business_conduct_and_ethics.pdf10
    Retaliation safeguardsYes2025code_of_business_conduct_and_ethics.pdf10
    Anti-discrimination policyYes2025code_of_business_conduct_and_ethics.pdf27
    Renewable Energy
    Total renewable energy consumption52%20252025RR.pdf69
    Supply Chain
    Combined scope 1 & 2 emissions150 100Metric Tons CO2e20252025RR.pdf69
    Number of employees15 410people2025Regeneron 2025 Annual Report.pdf38
    Scope 3 emissions1 103 000Metric Tons CO2e20252025RR.pdf69
    Union Formation and Collective Bargaining Power
    Number of employees15 106Employees20242024RR.pdf60
    Collective bargaining agreements coverage0employees2024Regeneron 2024 Annual Report.pdf36
    Recycling and Recovery of Waste
    Waste recycled30%20252025RR.pdf69
    Women on Board
    Women on supervisory board4people2025Regeneron 2026 Proxy Statement.pdf14
    Supervisory board size13people2025Regeneron 2026 Proxy Statement.pdf14
    Executive board size8people2025Regeneron 2026 Proxy Statement.pdf53
    Women on executive board1Executive2025Regeneron 2026 Proxy Statement.pdf53
    Women in Management
    Women in management36%20252025RR.pdf68
    Note: The PDF pages given here refer to the page in the PDF document, which is not necessarily the one found in the footer of the page. For example, page 10 is the 10th page in the document, even if it is labeled as page 8.

    Find more sustainable companies

    logo
    HomeFind Companies & ETFsLearn to investAcademyGlossaryOur Method
    ImprintPrivacy PolicyGTCFAQContact Us
    © 2026 money:care GmbHDisclaimerThe information provided is for informational purposes only and does not constitute an offer, recommendation, or investment advice to buy or sell financial instruments. Nor may they or any part of them be used as a basis for concluding a contract. They have been adopted in good faith from publicly accessible sources. No liability can be assumed for their accuracy. Any financial instrument referred to in this information and documents may be unsuitable for the respective investor to whom it is addressed. The recipients of such information and documents are responsible for independently evaluating and reviewing the products, assets, and financial instruments mentioned therein. Investors must make their own assessment of the suitability of the financial instruments mentioned herein based on the benefits and risks associated with the acquisition of the products, as well as on the basis of their own investment strategy and their legal, tax, and financial situation. Should readers use the content offered or follow any advice, they act on their own responsibility.The source of ETF data is the websites and data sheets of the respective ETF providers.The information contained in the company descriptions is generated by artificial intelligence and is for informational purposes only. While we strive for accuracy, the content may not be entirely reliable or comprehensive. We recommend cross-referencing the AI-generated content with other reliable sources to verify it and gain a more comprehensive understanding of the respective companies.Some links are affiliate links. If you click on these links and open an account, we will receive a small commission. Don't worry, you won't incur any additional costs. Thank you for your support!Logos provided by Logo.dev